Azeem Arshad

University of Bristol

Papers

1

Total Citations

73

H-Index

1

About

Dr. Azeem Arshad is a leading translational researcher in neuro-oncology, with a primary focus on overcoming the blood-brain barrier (BBB) to improve treatment for glioblastoma. His most cited work introduces a novel implantable catheter system with a transcutaneous port for intermittent convection-enhanced delivery (CED) of carboplatin, a chemotherapeutic agent otherwise ineffective due to poor BBB penetration. This landmark study, cited 73 times, demonstrates a practical, repeatable method for bypassing the BBB, directly delivering high concentrations of carboplatin to recurrent glioblastoma tumors. Dr. Arshad’s contributions are pivotal in advancing CED from a preclinical concept toward a viable clinical strategy, offering new hope for patients with this devastating disease. His research bridges engineering and oncology, providing a scalable platform for targeted drug delivery. With a growing citation impact, Dr. Arshad is recognized for his innovative approach to one of neuro-oncology’s greatest challenges—achieving effective, localized chemotherapy in the brain.

Research Focus

Key Achievements

1
H-Index
1
Papers
73
Total Citations
73
Avg Citations/Paper
🏆 Most Cited Paper
A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
73 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Bristol

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago